Data Collective IV GP, LLC
- SEC CIK
- 0001664974
- Latest filing
- Aug 14, 2026
Holdings in Q1 2025
Holdings as of Mar 31, 2025, filed May 15, 2025. Long positions only; changes compare share counts with Q4 2024.
- Positions
- 5
- −1 vs. Q4 2024
- Portfolio value
- $86.9M
- −$139.4M (−61.6%) vs. Q4 2024
| Security | Class | Shares | Value | % of portfolio | Share change | Action | History |
|---|---|---|---|---|---|---|---|
| RXRXRecursion Pharmaceuticals, Inc. | CL A | 5,941,120 | $31.4M | 36.2% | 00.0% | Unchanged | History |
| EVLVEvolv Technologies Holdings, Inc. | COM CL A | 9,681,281 | $30.2M | 34.8% | 00.0% | Unchanged | History |
| RKLBRocket Lab Corp | COM | 1,377,943 | $24.6M | 28.4% | 00.0% | Unchanged | History |
| DFTXDefinium Therapeutics, Inc. | Stock | 100,350 | $587.0K | 0.7% | 00.0% | Unchanged | History |
| ROIVRoivant Sciences Ltd. | SHS | 3,875 | $39.1K | <0.1% | 00.0% | Unchanged | History |
Sold out since Q4 2024 (1)
Positions held at the end of Q4 2024 that are gone from this filing.